Home » Archive

News

News, Syndication »

Connect names McKee as new CEO

Posted by sandiegobiotech March 4th, 2014 .
No Comments

Connect names entrepreneur Greg Mc Kee CEO, succeeding Duane Roth.

More...

News, Syndication, UCSD News »

UC San Diego-Human Longevity Inc. Agreement Seeks to Accelerate Medical Science

Posted by sandiegobiotech March 4th, 2014 .
No Comments

The new collaborative research agreement between Human Longevity Inc. (HLI) and the University of California, San Diego, announced today, represents a significant and necessary step in efforts to research and translate the potential of t…

More...

News, Syndication »

Craig Venter’s Latest Startup Gets $70M To Sequence Loads of Genomes

Posted by sandiegobiotech March 4th, 2014 .
No Comments

J. Craig Venter, the human genome pioneer, today unveiled a new San Diego-based venture with an ambitious goal of providing whole genome sequencing and cell-therapy-based diagnostic services for…

[[Click headline to continue reading.]]

More...

News, Syndication, UCSD News »

In First Moments of Infection, a Division and a Decision

Posted by sandiegobiotech March 4th, 2014 .
No Comments

Using technologies and computational modeling that trace the destiny of single cells, researchers at the University of California, San Diego School of Medicine describe for the first time the earliest stages of fate determ…

More...

News, Syndication, Xconomy »

Supreme Court Should Scale Back Securities Class Actions

Posted by sandiegobiotech March 4th, 2014 .
No Comments

Class-action lawsuits against publicly traded companies, which ironically are meant to protect investors like me, have officially jumped the shark.  That was the only conclusion I could come to after…

[[Click headline to continue reading.]]

More...

News, Syndication »

Targazyme, Inc. Appoints Dr. Mark W. Schwartz to Board of Directors

Posted by sandiegobiotech March 4th, 2014 .
No Comments

Targazyme, Inc. Appoints Dr. Mark W. Schwartz to Board of Directors

More...

News, Syndication »

Why It’s Time to Retire the Term “Life Sciences”

Posted by sandiegobiotech March 4th, 2014 .
No Comments

I originally thought about titling this piece “Life Sciences, Biosciences, BioPharma, Biotech, and Healthcare: What’s the Difference?” but that was simply too unwieldy. Many people use these terms…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

PacBio, the Post-Hype Sleeper of Genomics

Posted by sandiegobiotech March 3rd, 2014 .
No Comments

Hype and biotech go hand in hand, but genomics takes exaggeration up a few extra notches. When genomics companies fail, they tend to crash especially hard. Yet every now and then, a company that’s…

[[Click headline to continue reading.]]

More...

News, Syndication »

Abide to Receive $50M Upfront in Collaboration with Celgene Corp.

Posted by sandiegobiotech March 2nd, 2014 .
No Comments

Privately held Abide Therapeutics Inc. has partnered with biotech titan Celgene Corp. to develop new drugs in inflammation and immunology, receiving $50 million upfront in the deal.

More...

News, Syndication »

Abide Receiving $50M Upfront in Collaboration With Celgene Corp.

Posted by sandiegobiotech February 28th, 2014 .
No Comments

Privately held Abide Therapeutics Inc. has partnered with biotech titan Celgene Corp. to develop new drugs in inflammation and immunology, receiving $50 million upfront in the deal.

More...